Skip to main content

AIGH Capital Management LLC

13F filer · CIK 0001835943
Reported Aug 7, 2026
Net buyer this quarter
13F portfolio value$1.59BU.S. long equity reported on 13F
Positions4216 new · 14 closed
Net flow last quarter+$141MBuys minus sells
Top 10 positions weight51.4%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 7, 202642 positions
SNDKSandisk Corp$339M21.35%0.10%-25.5%Q3 2025
MXLMaxlinear, Inc$105M6.60%0.90%Not reportedQ3 2025
INTCIntel Corp$87.1M5.49%0.01%NewQ2 2026
APPSDigital Turbine, Inc.$84.5M5.32%5.41%+33.8%Q1 2023
SIMOSilicon Motion Technology CORP$48M3.03%0.11%-28.0%Q3 2021
CLFDClearfield, Inc.$40.1M2.53%7.42%NewQ2 2026
MEIMethode Electronics Inc$31.8M2.01%4.73%NewQ2 2026
ASYSAmtech Systems Inc$28.9M1.82%7.15%Not reportedQ3 2021
FENCFennec Pharmaceuticals Inc.$26.7M1.68%7.10%+25.5%Q1 2023
KYTXKyverna Therapeutics, Inc.$24.9M1.57%4.54%+39.8%Q4 2025
NYXHNyxoah SA$24.6M1.55%33.78%NewQ2 2026
PSNLPersonalis, Inc.$23M1.45%1.61%-40.9%Q3 2024
SOPHSOPHiA GENETICS SA$22.8M1.44%5.77%NewQ2 2026
DDD3d Systems Corp$22M1.38%4.95%NewQ2 2026
VUZIVuzix Corp$19.6M1.23%7.99%+104.7%Q4 2020
ABEOAbeona Therapeutics Inc.$18.5M1.16%5.22%-3.7%Q4 2021
ARDXArdelyx, Inc.$16.3M1.03%1.28%Not reportedQ4 2021
BDSXBiodesix Inc$15.3M0.96%6.43%-10.6%Q4 2022
SPRBSpruce Biosciences, Inc.$13.5M0.85%9.08%Not reportedQ1 2023
CSTLCastle Biosciences Inc$13M0.82%1.79%-7.7%Q3 2025
VNDAVanda Pharmaceuticals Inc.$12.5M0.79%3.38%-25.7%Q4 2020
PTHSPelthos Therapeutics Inc.$9.3M0.59%8.85%NewQ2 2026
PYPDPolyPid Ltd.$7.64M0.48%8.27%-5.6%Q1 2024
VSTMVerastem, Inc.$7.36M0.46%2.13%-3.7%Q4 2024
BWENBroadwind, Inc.$5.58M0.35%4.94%Not reportedQ1 2023
LIDRAEye, Inc.$5.55M0.35%8.29%NewQ2 2026
KIDSOrthopediatrics Corp$5.16M0.33%1.05%NewQ2 2026
APYXApyx Medical Corp$5.07M0.32%2.68%+2.1%Q1 2023
IPWRIdeal Power Inc.$4.8M0.30%5.45%-24.3%Q4 2020
TLPHTalphera, Inc.$4.74M0.30%8.87%-1.3%Q3 2025
TYGOTigo Energy, Inc.$4.64M0.29%2.59%-72.7%Q1 2026
WATTEnergous Corp$4.38M0.28%3.29%-15.4%Q1 2026
RNXTRenovoRx, Inc.$4.32M0.27%9.76%+18.9%Q1 2025
RELLRichardson Electronics, Ltd.$3.81M0.24%1.86%NewQ2 2026
NRXSNeuraxis, INC$3.8M0.24%4.17%+30.0%Q1 2025
COYACoya Therapeutics, Inc.$3.7M0.23%2.69%-35.2%Q4 2022
INVEIdentiv, Inc.$3.65M0.23%6.02%+254.2%Q1 2026
ELUTElutia Inc.$2.64M0.17%415.56%-25.0%Q3 2023
APREAprea Therapeutics, Inc.$815K0.05%8.20%Not reportedQ1 2023
BFRIBiofrontera Inc.$700K0.04%5.21%-19.2%Q1 2024
QNRXQuoin Pharmaceuticals, Ltd.$339K0.02%0.10%+37.3%Q4 2025
NNBRNN Inc$41.3K0.00%0.02%NewQ2 2026
Q1 2026Reported Apr 30, 202640 positions
SNDKSandisk Corp$127M17.33%0.14%-28.6%Q3 2025
TYGOTigo Energy, Inc.$27.4M3.73%9.60%NewQ1 2026
SIMOSilicon Motion Technology CORP$22.5M3.06%0.15%Not reportedQ3 2021
ZBRAZebra Technologies Corp$20.9M2.85%0.20%NewQ1 2026
LASRNlight, Inc.$19.4M2.64%0.60%-43.3%Q2 2025
VNDAVanda Pharmaceuticals Inc.$19M2.59%4.57%+37.6%Q4 2020
PSNLPersonalis, Inc.$18.5M2.52%2.77%Not reportedQ3 2024
GNRCGenerac Holdings Inc.$17.6M2.40%0.15%NewQ1 2026
KYTXKyverna Therapeutics, Inc.$17.3M2.35%3.30%+33.3%Q4 2025
CSTLCastle Biosciences Inc$14.5M1.98%1.95%-5.5%Q3 2025
APPSDigital Turbine, Inc.$14.1M1.92%4.07%Not reportedQ1 2023
RRXRegal Rexnord Corp$14M1.92%0.11%NewQ1 2026
ABEOAbeona Therapeutics Inc.$13.9M1.89%5.45%+55.0%Q4 2021
LRMRLarimar Therapeutics, Inc.$13.5M1.84%2.89%+50.0%Q3 2025
FENCFennec Pharmaceuticals Inc.$12.2M1.66%5.74%+25.3%Q1 2023
ESPREsperion Therapeutics, Inc.$12.1M1.64%1.71%+10.0%Q3 2025
ZVRAZevra Therapeutics, Inc.$11.2M1.53%2.03%Not reportedQ2 2024
BDSXBiodesix Inc$11M1.50%7.50%Not reportedQ4 2022
IDNIntellicheck, Inc.$10.6M1.45%7.50%+25.0%Q1 2024
VSTMVerastem, Inc.$10.6M1.45%2.28%Not reportedQ4 2024
TARAProtara Therapeutics, Inc.$8.45M1.15%2.95%NewQ1 2026
VUZIVuzix Corp$7.61M1.04%3.96%Not reportedQ4 2020
PYPDPolyPid Ltd.$6.98M0.95%8.75%+18.7%Q1 2024
APYXApyx Medical Corp$4.08M0.56%2.64%Not reportedQ1 2023
COYACoya Therapeutics, Inc.$3.84M0.52%4.16%Not reportedQ4 2022
ELUTElutia Inc.$3.78M0.51%554.24%+17.2%Q3 2023
RNXTRenovoRx, Inc.$3.68M0.50%8.23%+30.8%Q1 2025
TLPHTalphera, Inc.$3.48M0.47%9.31%Not reportedQ3 2025
WATTEnergous Corp$3.37M0.46%3.91%NewQ1 2026
IPWRIdeal Power Inc.$3.34M0.46%9.76%+140.2%Q4 2020
NRXSNeuraxis, INC$2.96M0.40%3.49%Not reportedQ1 2025
BKTIBK Technologies Corp$2.43M0.33%0.87%-84.6%Q2 2021
LPCNLipocine Inc.$1.6M0.22%2.68%NewQ1 2026
INVEIdentiv, Inc.$1.51M0.21%1.71%NewQ1 2026
LPTHLightpath Technologies Inc$1M0.14%0.16%-90.3%Q4 2020
RGNTRegentis Biomaterials Ltd.$917K0.12%5.79%NewQ1 2026
APREAprea Therapeutics, Inc.$775K0.11%8.48%+174.1%Q1 2023
BFRIBiofrontera Inc.$740K0.10%7.71%Not reportedQ1 2024
QNRXQuoin Pharmaceuticals, Ltd.$337K0.05%0.07%+3.4%Q4 2025
SMTKSmartKem, Inc.$204K0.03%4.22%+32.7%Q2 2024
Q4 2025Reported Feb 2, 202631 positions
SNDKSandisk Corp$66.5M16.09%0.19%Not reportedQ3 2025
CSTLCastle Biosciences Inc$24.3M5.88%2.10%-11.7%Q3 2025
PSNLPersonalis, Inc.$23.1M5.59%2.83%-25.5%Q3 2024
LASRNlight, Inc.$22.5M5.45%1.17%Not reportedQ2 2025
DAWNDay One Biopharmaceuticals, Inc.$18.6M4.49%1.93%+31.0%Q3 2025
VNDAVanda Pharmaceuticals Inc.$17.6M4.27%3.38%Not reportedQ4 2020
BKTIBK Technologies Corp$15.8M3.82%5.66%+113.6%Q2 2021
DOMODomo, Inc.$15.5M3.75%Not reported+37.0%Q1 2025
ESPREsperion Therapeutics, Inc.$14.8M3.58%1.67%+33.3%Q3 2025
KYTXKyverna Therapeutics, Inc.$14.1M3.41%2.48%NewQ4 2025
FENCFennec Pharmaceuticals Inc.$12.2M2.95%4.63%+132.1%Q1 2023
LPTHLightpath Technologies Inc$11.1M2.69%1.89%+14.5%Q4 2020
ABEOAbeona Therapeutics Inc.$10.5M2.55%3.63%Not reportedQ4 2021
IDNIntellicheck, Inc.$8.11M1.96%6.00%Not reportedQ1 2024
LRMRLarimar Therapeutics, Inc.$7.62M1.84%2.41%+100.0%Q3 2025
ARQArq, Inc.$7.43M1.80%5.32%-11.9%Q2 2024
ARDXArdelyx, Inc.$6.7M1.62%0.47%+479.4%Q4 2021
BYRNByrna Technologies Inc.$6.63M1.60%1.74%NewQ4 2025
PYPDPolyPid Ltd.$5.83M1.41%7.38%+26.1%Q1 2024
COYACoya Therapeutics, Inc.$5.66M1.37%4.66%-11.8%Q4 2022
TLPHTalphera, Inc.$5.31M1.29%9.45%+4.7%Q3 2025
APYXApyx Medical Corp$3.87M0.94%2.64%Not reportedQ1 2023
RNXTRenovoRx, Inc.$3.67M0.89%7.74%+8.4%Q1 2025
GRCEGrace Therapeutics, Inc.$3.15M0.76%5.86%Not reportedQ4 2024
ELUTElutia Inc.$2.13M0.51%472.99%-3.1%Q3 2023
NRXSNeuraxis, INC$1.82M0.44%3.75%Not reportedQ1 2025
IPWRIdeal Power Inc.$1.52M0.37%5.76%-4.1%Q4 2020
SMTKSmartKem, Inc.$719K0.17%9.87%+58.7%Q2 2024
QNRXQuoin Pharmaceuticals, Ltd.$712K0.17%0.09%NewQ4 2025
BFRIBiofrontera Inc.$522K0.13%7.86%-12.5%Q1 2024
APREAprea Therapeutics, Inc.$316K0.08%4.52%-31.3%Q1 2023
Q3 2025Reported Oct 31, 202534 positions
SNDKSandisk Corp$31.4M8.85%0.19%NewQ3 2025
PSNLPersonalis, Inc.$25.4M7.15%4.39%+4.5%Q3 2024
DOMODomo, Inc.$21.2M5.99%Not reportedNot reportedQ1 2025
ARQArq, Inc.$18.5M5.20%6.04%-2.8%Q2 2024
MXLMaxlinear, Inc$17.8M5.02%1.27%NewQ3 2025
LASRNlight, Inc.$17.8M5.01%1.18%Not reportedQ2 2025
CSTLCastle Biosciences Inc$16.1M4.54%2.43%NewQ3 2025
LUMNLumen Technologies, Inc.$15.6M4.40%0.25%NewQ3 2025
ZVRAZevra Therapeutics, Inc.$11.7M3.30%2.19%+34.1%Q2 2024
DAWNDay One Biopharmaceuticals, Inc.$10.7M3.02%1.48%NewQ3 2025
APPSDigital Turbine, Inc.$9.75M2.75%1.36%Not reportedQ1 2023
BKTIBK Technologies Corp$8.36M2.36%2.65%Not reportedQ2 2021
VPGVishay Precision Group, Inc.$8.01M2.26%2.04%-41.0%Q1 2025
ESPREsperion Therapeutics, Inc.$7.95M2.24%1.49%NewQ3 2025
LPTHLightpath Technologies Inc$7.14M2.01%2.10%-75.3%Q4 2020
FENCFennec Pharmaceuticals Inc.$6.38M1.80%2.43%+50.6%Q1 2023
COYACoya Therapeutics, Inc.$6.3M1.78%6.60%Not reportedQ4 2022
VELOVelo3D, Inc.$5.28M1.49%8.22%NewQ3 2025
PHATPhathom Pharmaceuticals, Inc.$5.05M1.42%0.60%NewQ3 2025
AMBAAmbarella Inc$4.13M1.16%0.12%NewQ3 2025
TLPHTalphera, Inc.$3.98M1.12%9.77%NewQ3 2025
PYPDPolyPid Ltd.$3.55M1.00%6.80%-10.8%Q1 2024
RNXTRenovoRx, Inc.$3.32M0.94%7.14%-24.6%Q1 2025
LRMRLarimar Therapeutics, Inc.$3.23M0.91%1.17%NewQ3 2025
ELUTElutia Inc.$2.82M0.79%487.93%-8.3%Q3 2023
VUZIVuzix Corp$2.81M0.79%1.13%Not reportedQ4 2020
GRCEGrace Therapeutics, Inc.$2.7M0.76%6.42%-19.6%Q4 2024
IPWRIdeal Power Inc.$2.58M0.73%6.03%-23.3%Q4 2020
NRXSNeuraxis, INC$1.23M0.35%4.05%Not reportedQ1 2025
ELVAElectrovaya Inc.$1.13M0.32%0.46%-91.1%Q3 2023
ARDXArdelyx, Inc.$1.09M0.31%0.08%Not reportedQ4 2021
BFRIBiofrontera Inc.$1.03M0.29%8.98%+7.3%Q1 2024
APREAprea Therapeutics, Inc.$795K0.22%9.02%Not reportedQ1 2023
SMTKSmartKem, Inc.$714K0.20%7.59%-3.1%Q2 2024
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.